# Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction

> **NCT00998218** · PHASE3 · COMPLETED · sponsor: **Aspirus Heart and Vascular Institute-Research and Education** · enrollment: 7 (actual)

## Conditions studied

- Sudden Cardiac Death
- Ventricular Arrythmias

## Interventions

- **DRUG:** Ranolazine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00998218
- **Lead sponsor:** Aspirus Heart and Vascular Institute-Research and Education
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2012-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00998218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00998218, "Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00998218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*